Nicholas Lee Gurreri Net Worth

What's Nicholas Gurreri's mailing address?

Nicholas's mailing address filed with the SEC is C/O INSMED INCORPORATED, 8720 STONY POINT PARKWAY, SUITE 200, RICHMOND, VA, 23235.

Insiders trading at Insmed Inc

Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis e Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.

What does Insmed Inc do?

insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.

Insmed Inc executives and stock owners

Insmed Inc executives and other stock owners filed with the SEC include:

• William Lewis,
  Chairman of the Board, President, Chief Executive Officer
• Roger Adsett,
  Chief Operating Officer
• Christine Pellizzari,
  Chief Legal Officer
• S. Nicole Schaeffer,
  Chief People Strategy Officer
• William H. Lewis J.D., M.B.A.,
  Pres, CEO & Chairman
• Dr. Martina Flammer M.B.A., M.D.,
  Chief Medical Officer
• John Goll,
  Chief Accounting Officer
• Roger Adsett,
  Chief Operating Officer
• Christine A. Pellizzari J.D.,
  Consultant
• Sara M. Bonstein MBA,
  Chief Financial Officer
• John Goll III,
  Sr. VP & Chief Accounting Officer
• David Brennan,
  Lead Independent Director
• Alfred Altomari,
  Independent Director
• Steinar Engelsen,
  Independent Director
• David McGirr,
  Independent Director
• Melvin Sharoky,
  Independent Director
• Leo Lee,
  Independent Director
• Elizabeth Anderson,
  Independent Director
• Clarissa Desjardins,
  Independent Director
• Carol Schafer,
  Director
• Martina Flammer,
  Chief Medical Officer
• John Soriano,
  Chief Compliance Officer
• Sara Bonstein,
  Chief Financial Officer
• S. Nicole Schaeffer,
  Chief People Strategy Officer
• Mandy Fahey,
  Sr. Director of Corp. Communications
• Michael Alexander Smith,
  Sr. VP & Gen. Counsel
• John D. Soriano J.D.,
  Chief Compliance Officer
• Eleanor Barisser,
  Associate Director of Investor Relations
• Paolo Tombesi,
  Chief Financial Officer
• Paul Streck,
  Chief Medical Officer
• Eugene Jeffrey Sullivan,
  Chief Medical Officer
• Myrtle S Potter,
  Director
• Donald J Jr Hayden,
  Director
• Geoffrey Allan,
  President, CEO and Chairman
• Stephen C. Glover,
  President Follow-on Biologics
• Doug Farrar,
  Vice President, ITP
• Michael Duncan,
  Principal Financial Officer
• Thomas A Keuer,
  VP, ITP (Subsidiary)
• Philip J Young,
  Chief Business Officer and EVP
• Ronald D Gunn,
  Executive Vice President
• Mark Quigley,
  Vice President, Quality
• Randall W Whitcomb,
  Director
• Peggy Berry,
  Vice President, Regulatory
• Renu Gupta,
  Chief Medical Officer
• Richard S Kollender,
  Director
• Matthew Pauls,
  Chief Commercial Officer
• Llc Fmr,
  10% owner
• Andrea Holtzman Drucker,
  Senior V.P., General Counsel
• Nicholas A. Jr. La Bella,
  Chief Scientific Officer
• Kenneth G Condon,
  Director
• Kevin P Tully,
  Executive VP & CFO
• Timothy Whitten,
  President & CEO
• Graham K Crooke,
  Director
• Nicholas Lee Gurreri,
  Senior VP, Commercial Ops
• Dennis M Lanfear,
  Director
• John Drayton Wise,
  Chief Commercial Officer
• Michael Alexander Smith,
  Chief Legal Officer